Post

New research · Ophthalmology
JAMA ophthalmology · 5d
Cross-sectionalJAMA ophthalmology · 2025

Commercial Price Variation in Ophthalmology.

Alexander P Philips, Christopher Whaley
Read paper
OphthalmologyCross-sectional

Facility fees for eye procedures vary far more across insurers than professional fees.

Commercial Price Variation in Ophthalmology.

Alexander P Philips, Christopher Whaley
JAMA ophthalmology · 2025
Purpose

To assess the variation in commercial insurance payment rates for common ophthalmology procedures across major national insurers and identify patterns in professional and facility fees.

Methods

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used January 2025 Transparency in Coverage data, payment rates negotiated between insurers and health care professionals from 4 large national insurers (Blue Cross Blue Shield, United Healthcare, Cigna, and Aetna) for 10 common ophthalmology procedures.

n = 684 506 professional fee price
2
Results
2
to 4
facility prices swing more between insurers than doctor fees do
n = 684 506 professional fee price
More results

Blue Cross Blue Shield maintained consistently higher payments (14% above market average for professional fees; 13% above for facility fees), while Aetna demonstrated dramatic variation with professional fees 54% below average but facility fees 45% above average.

More results

Geographic analysis revealed substantial state-level variability, with facility prices for standard cataract surgeries showing up to 5-fold differences between upper and lower bounds across states.

“
Conclusion · 1 of 2

This study reveals substantial variability in commercial insurance payment rates for ophthalmology procedures, particularly in facility fees.

Conclusion · 2 of 2

These findings indicate that market dynamics, insurer-health care professional negotiations, and geographic factors substantially influence price variation, which has important implications for health care affordability and access to ophthalmologic care.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment